Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (1001-1010 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|August 23, 2012
Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, GermanyAlain Beck, John Lambert, Michael Sun, et al.
Mabs|June 16, 2012
Marketing approval of mogamulizumab: a triumph for glyco-engineeringAlain Beck, Janice M Reichert
Mabs|June 16, 2012
Pharmacokinetics of engineered human monomeric and dimeric CH2 domainsKurt Gehlsen, Rui Gong, Dave Bramhill, et al.
Mabs|February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicityStefanie Derer, Pia Glorius, Martin Schlaeth, et al.
Mabs|February 5, 2014
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human useMisty W Stevens, Rachel L Tawney, C Michael West, et al.
Mabs|February 5, 2014
The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancerSiqi Han, Yanchun Meng, Qing Tong, et al.
Mabs|February 5, 2014
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studiesDanielle J Vugts, Derrek A Heuveling, Marijke Stigter-van Walsum, et al.
Mabs|February 5, 2014
Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycleOrnnuthchar Poungpair, Kunan Bangphoomi, Prapaipit Chaowalit, et al.
Mabs|February 5, 2014
Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platformThomas Schirrmann, André Frenzel, Lars Linden, et al.
Mabs|February 5, 2014
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune librarySebastian Miethe, Christine Rasetti-Escargueil, Yvonne Liu, et al.
Pageof 184

Showing results (1001-1010 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|August 23, 2012
Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, GermanyAlain Beck, John Lambert, Michael Sun, et al.
Mabs|June 16, 2012
Marketing approval of mogamulizumab: a triumph for glyco-engineeringAlain Beck, Janice M Reichert
Mabs|June 16, 2012
Pharmacokinetics of engineered human monomeric and dimeric CH2 domainsKurt Gehlsen, Rui Gong, Dave Bramhill, et al.
Mabs|February 5, 2014
Increasing FcγRIIa affinity of an FcγRIII-optimized anti-EGFR antibody restores neutrophil-mediated cytotoxicityStefanie Derer, Pia Glorius, Martin Schlaeth, et al.
Mabs|February 5, 2014
Preclinical characterization of an anti-methamphetamine monoclonal antibody for human useMisty W Stevens, Rachel L Tawney, C Michael West, et al.
Mabs|February 5, 2014
The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancerSiqi Han, Yanchun Meng, Qing Tong, et al.
Mabs|February 5, 2014
Preclinical evaluation of 89Zr-labeled anti-CD44 monoclonal antibody RG7356 in mice and cynomolgus monkeys: Prelude to Phase 1 clinical studiesDanielle J Vugts, Derrek A Heuveling, Marijke Stigter-van Walsum, et al.
Mabs|February 5, 2014
Generation of human single-chain variable fragment antibodies specific to dengue virus non-structural protein 1 that interfere with the virus infectious cycleOrnnuthchar Poungpair, Kunan Bangphoomi, Prapaipit Chaowalit, et al.
Mabs|February 5, 2014
Evaluation of human pancreatic RNase as effector molecule in a therapeutic antibody platformThomas Schirrmann, André Frenzel, Lars Linden, et al.
Mabs|February 5, 2014
Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune librarySebastian Miethe, Christine Rasetti-Escargueil, Yvonne Liu, et al.
Pageof 184